Pregled bibliografske jedinice broj: 49781
Proximal diabetic neuropathy - clinical signs and neurophysiological parameters
Proximal diabetic neuropathy - clinical signs and neurophysiological parameters // European Neurological Congress : abstracts ; u: Journal of Neurology / Scolding, N.J. (ur.).
Bristol: ENS, 1998. str. 489-489 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 49781 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Proximal diabetic neuropathy - clinical signs and neurophysiological parameters
Autori
Barada, Ante ; Reljanović, Miroslav ; Miličević, Zvonko ; Car, Nikica ; Ljubić, Spomenka ; Profozić, Velimir ; Metelko, Željko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
European Neurological Congress : abstracts ; u: Journal of Neurology
/ Scolding, N.J. - Bristol : ENS, 1998, 489-489
Skup
European Neurological Congress
Mjesto i datum
Nica, Francuska, 04.06.1998. - 10.06.1998
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
PDN
Sažetak
The aim of the study was to define the characteristic neurophysiological parameters and clinical signs of proximal diabetic neuropathy (PDN). Twelve patients with PDN (Group 1) and 30 patients with distal symmetric diabetic polyneuropathy (DSDP) but without signs and symptoms of PDN (Group 2) were examined. The groups were comparable with regard to age, gender and diabetes duration. In Group 1 all patients had type 2 diabetes, mean PDN symptoms duration 4.3 + 1.8 months, whereas duration of distal polyneuropathy symptoms in the same patients was 3.2 + 2.3 yrs. Clinical picture in all Group 1 patients was characterised by pronounced pain in the upper legs (mean visual analogue scale value = 7.4 cm), atrophy of upper leg muscles, loss of predominantly pelvifemoral muscle strength and significant weight loss. Bilaterally affected upper legs were recorded in 9 patients and unilateral in 3. Among neurophysiological parameters significant difference between Group 1 and Group 2 was found in motor conduction velocity of femoral nerve (37.3 vs. 61.4 m/s, p<0.0001), while no significant difference was found for peroneal and sural nerves. PDN is present in type 2 diabetics and is characterised by pain, muscle atrophy in upper legs, weight loss and reduced motor conduction velocity of femoral nerve.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
045006
Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Profili:
Ante Barada
(autor)
Nikica Car
(autor)
Zvonko Miličević
(autor)
Željko Metelko
(autor)
Spomenka Ljubić
(autor)
Velimir Profozić
(autor)
Miroslav Reljanović
(autor)